Showing 871-880 of 3001 results for "".
Update in Epilepsy Therapeutics
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/update-in-epilepsy-therapeutics/30511/In addition to comorbid conditions and side effects, cost and availability should factor into therapeutic selection.An Update on Antiplatelet Therapy for Secondary Stroke Prevention
https://practicalneurology.com/diseases-diagnoses/stroke/PN0809_03-php/30895/Recent data on stroke, insights from other specialties, and developments in the antiplatelet arena may influence management of stroke patients.In the Pipeline
https://practicalneurology.com/columns/practice-management/in-the-pipeline/30821/Telepresence in Neurology
https://practicalneurology.com/columns/practice-management/telepresence-in-neurology/30389/Pain and Gain: Reassessing Hydrocodone Prescribing
https://practicalneurology.com/diseases-diagnoses/headache-pain/pain-and-gain-reassessing-hydrocodone-prescribing/30742/New recommendations by an FDA committee aim to decrease opioid abuse, the group says, but will physicians and patients bear the burden of its effects?Letter to the Editor: At Face Value: Obama and Neurology
https://practicalneurology.com/columns/practice-management/1109_06-php/30875/Remote Work Balances Life
https://practicalneurology.com/columns/practice-management/remote-work-balances-life/30354/Clarification of Call Coverage: Always a Duty of Neurologists
https://practicalneurology.com/columns/practice-management/PN0809_06-php/30897/New Diagnostic Tool Approved for Evaluation of Dementia Patients
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/new-diagnostic-tool-approved-for-evaluation-of-dementia-patients/30778/Amyvid, which indicates levels of beta-amyloid plaques in the brain, can help guide the diagnosis of dementia.Impaired Driving Related to Medications and Neurological Diagnoses
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/impaired-driving-related-to-medications-and-neurological-diagnoses/30686/Researchers investigated the degree to which various common agents, including benzodiazepines and non-benzodiazepine hypnotics, may affect driving ability. Therapy selection and patient counseling are key to safe use.